The estimated Net Worth of Bryant David Lim is at least $759 Тысяча dollars as of 24 May 2023. Mr. Lim owns over 2,400 units of Idera Pharmaceuticals stock worth over $1,032 and over the last 6 years he sold IDRA stock worth over $26,162. In addition, he makes $731,795 as Senior Vice President, General Counsel и Corporate Secretary at Idera Pharmaceuticals.
Bryant has made over 6 trades of the Idera Pharmaceuticals stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 2,400 units of IDRA stock worth $12,936 on 24 May 2023.
The largest trade he's ever made was selling 7,630 units of Idera Pharmaceuticals stock on 25 March 2021 worth over $10,377. On average, Bryant trades about 990 units every 85 days since 2018. As of 24 May 2023 he still owns at least 2,400 units of Idera Pharmaceuticals stock.
You can see the complete history of Mr. Lim stock trades at the bottom of the page.
Bryant David Lim J.D. serves as Senior Vice President, General Counsel, Corporate Secretary of the Company. Mr. Lim most recently served as Vice President, Assistant General Counsel of Incyte Corporation. Prior to Incyte, Mr. Lim held roles of increasing responsibility at ViroPharma Incorporated, Merck & Co., Inc. and Morgan, Lewis & Bockius, LLP. Mr. Lim began his legal career as a law clerk for a federal judge. Mr. Lim received his J.D. from Villanova University School of Law, where he serves on its adjunct faculty. Mr. Lim received his Bachelor of Arts from University of Rochester.
As the Senior Vice President, General Counsel и Corporate Secretary of Idera Pharmaceuticals, the total compensation of Bryant Lim at Idera Pharmaceuticals is $731,795. There are 2 executives at Idera Pharmaceuticals getting paid more, with Vincent Milano having the highest compensation of $1,337,220.
Bryant Lim is 49, he's been the Senior Vice President, General Counsel и Corporate Secretary of Idera Pharmaceuticals since 2018. There are 15 older and 1 younger executives at Idera Pharmaceuticals. The oldest executive at Idera Pharmaceuticals, Inc. is Dr. Sudhir Agrawal D.Phil., DPHIL, F.R.S.C., 67, who is the Scientific Advisor.
Bryant's mailing address filed with the SEC is 505 Eagleview Blvd, Exton, PA 19341, USA.
Over the last 17 years, insiders at Idera Pharmaceuticals have traded over $20,746,904 worth of Idera Pharmaceuticals stock and bought 38,459,430 units worth $53,771,070 . The most active insiders traders include Bros. Advisors Lp14159, L.P..., Bros. Advisors Lp Baker Bro... и Invest Corp Pillar Pharmace.... On average, Idera Pharmaceuticals executives and independent directors trade stock every 43 days with the average trade being worth of $309,429. The most recent stock trade was executed by John J. Kirby on 17 December 2021, trading 10,000 units of IDRA stock currently worth $6,200.
Harnessing the approach of the earliest researchers in immunotherapy and the company's vast experience in developing proprietary immunology platforms, Idera's development program is focused on priming the immune system to play a more powerful role in fighting cancer, ultimately increasing the number of people who can benefit from immunotherapy. Idera also continues to focus on the acquisition, development, and ultimate commercialization of drug candidates for both oncology and rare disease indications characterized by small, well-defined patient populations with serious unmet needs.
Idera Pharmaceuticals executives and other stock owners filed with the SEC include: